We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Novel Mammogram Measures Could Revolutionize Screening

By MedImaging International staff writers
Posted on 06 Jan 2021
Print article
Image: New mammographic measures could help stratify breast cancer risk (Photo courtesy of Getty Images)
Image: New mammographic measures could help stratify breast cancer risk (Photo courtesy of Getty Images)
Two new mammogram-based measures of breast cancer (BC) risk are more effective in stratifying women than breast density and genetic risk factors, according to a new study.

Developed at the University of Melbourne (UNIMELB; Melbourne, Australia), Cancer Council Victoria (Melbourne, Australia), Monash University (Melbourne, Australia), and other institutions, the new mammogram‐based BC risk measures are based on image brightness (Cirrocumulus) and texture (Cirrus). Semi-automated measures of density are repeated under increasingly higher levels of brightness to create Cirrocumulus; artificial intelligence (AI) and high-speed computing resolve new aspects of the texture of a mammogram to create Cirrus.

When combined, the new measures show twice the risk gradient for the screen‐detected established measure of conventional mammographic density (Cumulus), as well as for younger‐diagnosis BC, and have at least the same discriminatory power as the current polygenic risk score. Cirrocumulus and Cirrus also show improved correlation with causal factors than conventional mammographic density, and could also help address the problem of dense breasts. The study was published on November 16, 2020, in the International Journal of Cancer.

“In terms of understanding how much women differ in their risks of breast cancer, these developments could be the most significant since the breast cancer genes BRCA1 and BRCA2 were discovered 25 years ago,” said senior author Professor John Hopper, MD, of UNIMELB. “As mammography is now digital, and our measures are now computerized, women could be assessed for their risk at the time of screening automatically and given recommendations for their future screening based on their personal risk, not just their age.”

Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.

Related Links:
University of Melbourne
Cancer Council Victoria
Monash University



Print article
Radcal
CIRS

Channels

Industry News

view channel
Illustration

Siemens Completes Acquisition of Varian to Create Integrated Portfolio of Imaging, Laboratory Diagnostics, AI and Cancer Treatment

Siemens Healthineers (Erlangen, Germany) has successfully completed the acquisition of Varian Medical Systems, Inc. (Palo Alto, CA, USA), thus strengthening its position as a holistic partner in healthcare.... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.